thiotepa has been researched along with Leukoma in 3 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson Penno, E | 1 |
Braun, DA | 1 |
Kamal, A | 1 |
Hamilton, WK | 1 |
Gimbel, HV | 1 |
LAVERGNE, G | 2 |
COLMANT, IA | 2 |
3 other studies available for thiotepa and Leukoma
Article | Year |
---|---|
Topical thiotepa treatment for recurrent corneal haze after photorefractive keratectomy.
Topics: Administration, Topical; Adult; Antineoplastic Agents, Alkylating; Astigmatism; Corneal Opacity; Hum | 2003 |
[INHIBITION OF CORNEAL VASCULARIZATION BY TRIETHYLENETHIO-PHOSPHORAMIDE. EXPERIMENTAL AND CLINICAL STUDY].
Topics: Blood Vessels; Corneal Opacity; Corneal Ulcer; Keratitis; Pharmacology; Phosphoramides; Rabbits; Res | 1963 |
COMPARATIVE STUDY OF THE ACTION OF THIOTEPA AND TRIAMCINOLONE ON CORNEAL VASCULARIZATION IN RABBITS.
Topics: Animals; Blood Vessels; Cautery; Cell Division; Cornea; Corneal Neovascularization; Corneal Opacity; | 1964 |